Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Pardes Biosciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
PRDS is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 0
- −1 vs. Q3 2023
- Shares held
- 0
- −31.0K (−100.0%) vs. Q3 2023
- Total value
- $0
- −$66.7K (−100.0%) vs. Q3 2023
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $66.7K |
| Q2 2023 | 59 | $63.9M |
| Q1 2023 | 60 | $48.6M |
| Q4 2022 | 64 | $63.8M |
| Q3 2022 | 67 | $87.2M |
| Q2 2022 | 68 | $143.7M |
| Q1 2022 | 57 | $282.3M |
| Q4 2021 | 41 | $573.0M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Pardes Biosciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 0 | $0 | 0.00% | −31,037−100.0% | Sold out |